ONTOLOGY REPORT - ANNOTATIONS
| Term: | nicotinic acid |
|
| Accession: | CHEBI:15940
|
browse the term
|
| Definition: | A pyridinemonocarboxylic acid in which the carboxy group is located at position 3. |
| Synonyms: | exact_synonym: | pyridine-3-carboxylic acid |
| | related_synonym: | 3-Pyridinecarboxylic acid; 3-Pyridylcarboxylic acid; 3-carboxypyridine; C6H5NO2; InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9); InChIKey=PVNIIMVLHYAWGP-UHFFFAOYSA-N; Niacin; Nikotinsaeure; OC(=O)c1cccnc1; P.P. factor; PP factor; acide nicotinique; acido nicotinico; acidum nicotinicum; anti-pellagra vitamin; beta-pyridinecarboxylic acid; m-pyridinecarboxylic acid; pellagra preventive factor; pyridine-beta-carboxylic acid; vitamin B3 |
| | alt_id: | CHEBI:25538; CHEBI:44319; CHEBI:7559 |
| | xref_casrn: | 59-67-6 |
| | xref: | Beilstein:109591 "Beilstein Registry Number"; ChEMBL:116656 "ChEMBL COMPOUND"; ChemIDplus:59-67-6 "CAS Registry Number"; CiteXplore:12563315 "PubMed citation"; CiteXplore:12789870 "PubMed citation"; CiteXplore:15037193 "PubMed citation"; CiteXplore:15183629 "PubMed citation"; CiteXplore:15205990 "PubMed citation"; CiteXplore:15311728 "PubMed citation"; CiteXplore:15627518 "PubMed citation"; CiteXplore:16018787 "PubMed citation"; CiteXplore:16172771 "PubMed citation"; CiteXplore:16400392 "PubMed citation"; CiteXplore:16449845 "PubMed citation"; CiteXplore:16767301 "PubMed citation"; CiteXplore:16877271 "PubMed citation"; CiteXplore:16945375 "PubMed citation"; CiteXplore:18037924 "PubMed citation"; CiteXplore:18993152 "PubMed citation"; CiteXplore:18996527 "PubMed citation"; CiteXplore:19369827 "PubMed citation"; CiteXplore:19592242 "PubMed citation"; CiteXplore:19678716 "PubMed citation"; CiteXplore:19779335 "PubMed citation"; CiteXplore:21632263 "PubMed citation"; CiteXplore:22116693 "PubMed citation"; CiteXplore:22155410 "PubMed citation"; CiteXplore:22366213 "PubMed citation"; CiteXplore:22458880 "PubMed citation"; CiteXplore:22770225 "PubMed citation"; DrugBank:DB00627 "DrugBank"; Gmelin:3340 "Gmelin Registry Number"; HMDB:HMDB01488 "HMDB"; KEGG COMPOUND:59-67-6 "CAS Registry Number"; KEGG COMPOUND:C00253 "KEGG COMPOUND"; KEGG DRUG:D00049 "KEGG DRUG" |
| | xref_mesh: | MESH:D009525 |
| | xref: | MetaCyc:NIACINE "MetaCyc"; NIST Chemistry WebBook:59-67-6 "CAS Registry Number"; PDBeChem:NIO "PDBeChem"; Reaxys:109591 "Reaxys Registry Number"; Wikipedia:Niacin "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:32544 |
|
|
nicotinic acid
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
multiple interactions |
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
multiple interactions |
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
decreases expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
decreases activity |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
affects abundance |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
multiple interactions |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
decreases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
multiple interactions |
ISO |
11 |
80,330,615 |
80,336,658 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
increases expression |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
increases expression |
EXP |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
decreases expression |
ISO |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Arhgap8 |
Rho GTPase activating protein 8 |
|
increases expression |
EXP |
7 |
122,730,224 |
122,794,430 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
multiple interactions |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
multiple interactions |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
decreases expression |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Btc |
betacellulin |
|
multiple interactions |
ISO |
14 |
18,194,470 |
18,235,228 |
RGD:6480464 |
CTD |
| G |
Casq1 |
calsequestrin 1 (fast-twitch, skeletal muscle) |
|
multiple interactions |
ISO |
13 |
88,200,506 |
88,210,418 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav3 |
caveolin 3 |
|
multiple interactions |
EXP |
4 |
148,294,428 |
148,310,380 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chn2 |
chimerin (chimaerin) 2 |
|
increases expression |
EXP |
4 |
82,649,232 |
82,678,513 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
multiple interactions |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Col4a3bp |
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
|
multiple interactions |
ISO |
2 |
27,012,330 |
27,117,057 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
decreases expression |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
multiple interactions |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Cst11 |
cystatin 11 |
|
increases expression |
EXP |
3 |
137,524,412 |
137,527,136 |
RGD:6480464 |
CTD |
| G |
Cst8 |
cystatin 8 (cystatin-related epididymal specific) |
|
increases expression |
EXP |
3 |
137,557,637 |
137,564,274 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
decreases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Ddhd1 |
DDHD domain containing 1 |
|
multiple interactions |
ISO |
15 |
21,500,775 |
21,569,296 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
multiple interactions |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
decreases activity |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
increases expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Ecel1 |
endothelin converting enzyme-like 1 |
|
increases expression |
EXP |
9 |
85,933,894 |
85,946,083 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
increases expression |
EXP |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
increases phosphorylation |
EXP |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
multiple interactions |
ISO |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
EXP |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gpi |
glucose-6-phosphate isomerase |
|
multiple interactions |
ISO |
1 |
86,658,836 |
86,686,712 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
affects binding |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
increases activity |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
affects activity |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
increases response to substance |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
EXP |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
EXP |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
EXP |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
EXP |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
affects activity |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
increases activity |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
affects localization |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Lcn5 |
lipocalin 5 |
|
increases expression |
EXP |
3 |
3,825,478 |
3,829,490 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
decreases activity |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
decreases expression |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Litaf |
lipopolysaccharide-induced TNF factor |
|
increases expression |
EXP |
10 |
4,614,177 |
4,623,903 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
increases expression |
EXP |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Net1 |
neuroepithelial cell transforming 1 |
|
multiple interactions |
ISO |
17 |
77,533,225 |
77,543,337 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases phosphorylation |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
EXP |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nrap |
nebulin-related anchoring protein |
|
multiple interactions |
ISO |
1 |
262,591,454 |
262,672,255 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
increases expression |
EXP |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
multiple interactions |
EXP |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
EXP |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
multiple interactions |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
decreases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pi16 |
peptidase inhibitor 16 |
|
multiple interactions |
ISO |
20 |
7,636,282 |
7,645,221 |
RGD:6480464 |
CTD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
decreases expression |
ISO |
9 |
13,057,988 |
13,100,289 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
increases activity |
ISO |
5 |
126,007,672 |
126,074,012 |
RGD:6480464 |
CTD |
| G |
Ptgdr |
prostaglandin D2 receptor |
|
multiple interactions |
ISO |
15 |
19,345,555 |
19,352,929 |
RGD:6480464 |
CTD |
| G |
Ptgds |
prostaglandin D2 synthase (brain) |
|
multiple interactions |
ISO |
3 |
3,632,683 |
3,635,617 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases expression |
EXP |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases response to substance |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Qprt |
quinolinate phosphoribosyltransferase |
|
increases abundance |
EXP |
1 |
186,358,523 |
186,374,681 |
RGD:6480464 |
CTD |
| G |
Ralgapa1 |
Ral GTPase activating protein, alpha subunit 1 (catalytic) |
|
multiple interactions |
ISO |
6 |
75,849,629 |
76,163,553 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
decreases expression |
ISO |
12 |
2,499,630 |
2,501,370 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rtn4r |
reticulon 4 receptor |
|
decreases expression |
EXP |
11 |
84,839,082 |
84,863,508 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
multiple interactions |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
multiple interactions |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
EXP |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
decreases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Spink5 |
serine peptidase inhibitor, Kazal type 5 |
|
increases expression |
EXP |
18 |
37,563,911 |
37,631,579 |
RGD:6480464 |
CTD |
| G |
Srl |
sarcalumenin |
|
multiple interactions |
ISO |
10 |
11,174,718 |
11,218,663 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
increases expression |
EXP |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
decreases activity |
EXP |
10 |
89,795,404 |
89,819,732 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
increases expression |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
increases expression |
EXP |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
increases phosphorylation |
EXP |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Tesc |
tescalcin |
|
increases expression |
EXP |
12 |
39,669,706 |
39,704,041 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
decreases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tln1 |
talin 1 |
|
multiple interactions |
ISO |
5 |
60,010,952 |
60,040,908 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
multiple interactions |
ISO |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Ttpa |
tocopherol (alpha) transfer protein |
|
multiple interactions |
ISO |
5 |
34,638,551 |
34,659,077 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vtn |
vitronectin |
|
increases expression |
ISO |
10 |
64,609,242 |
64,612,322 |
RGD:6480464 |
CTD |
1-methylnicotinamide
|
| G |
Lepr |
leptin receptor |
|
affects abundance |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases import |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases import |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
N-methylnicotinamide
|
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
affects abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
N-ribosylnicotinamide
|
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
multiple interactions |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
increases oxidation |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
nicotinamide
|
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
decreases phosphorylation |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases secretion |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
multiple interactions |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases phosphorylation |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
EXP |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
multiple interactions |
EXP |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
multiple interactions |
EXP |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
multiple interactions |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
multiple interactions |
EXP |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
multiple interactions |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Mafa |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) |
|
multiple interactions |
ISO |
7 |
113,707,043 |
113,708,128 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
decreases expression |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
multiple interactions |
ISO |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases activity |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
multiple interactions |
EXP |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
multiple interactions |
EXP |
5 |
26,234,414 |
26,240,301 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases acetylation |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
ISO |
2 |
54,327,821 |
54,360,462 |
RGD:6480464 |
CTD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
multiple interactions |
ISO |
5 |
126,007,672 |
126,074,012 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
multiple interactions |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
EXP |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases expression |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases expression |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt2 |
sirtuin 2 |
|
decreases activity |
ISO |
1 |
83,873,578 |
83,896,121 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
affects abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
decreases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
Term paths to the root
| Path 1 |
CHEBI ontology |
492574 |
 |
role |
482262 |
 |
biological role |
480454 |
 |
physiological role |
474282 |
 |
| vitamin |
8797 |
 |
nicotinic acid |
391 |
 |
| 1,4,5,6-tetrahydro-6-oxonicotinic acid |
0 |
 |
| 2,6-dihydroxynicotinic acid |
0 |
 |
| 2-aminonicotinic acid |
0 |
 |
| 4-aminonicotinic acid |
0 |
 |
| 4-methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid |
0 |
 |
| 5-aminonicotinic acid |
0 |
 |
| 5-hydroxy-6-methylpyridine-3-carboxylic acid |
0 |
 |
| 5-pyridoxic acid + |
0 |
 |
| 6-aminonicotinic acid |
0 |
 |
| 6-hydroxynicotinic acid |
0 |
 |
| D-ribosylnicotinic acid |
0 |
 |
| Euphorbia diterpenoid 2 |
0 |
 |
| N-methylnicotinic acid |
0 |
 |
| cyclitol nicotinate + |
0 |
 |
| inositol hexanicotinate + |
0 |
 |
| myo-inositol hexanicotinate |
0 |
 |
| nicotinamide + |
135 |
 |
| Path 2 |
CHEBI ontology |
492574 |
 |
subatomic particle |
491537 |
 |
composite particle |
491537 |
 |
hadron |
491537 |
 |
baryon |
491537 |
 |
nucleon |
491537 |
 |
atomic nucleus |
491537 |
 |
atom |
491537 |
 |
main group element atom |
461203 |
 |
p-block element atom |
458699 |
 |
carbon group element atom |
410677 |
 |
carbon atom |
407233 |
 |
| organic molecular entity |
407226 |
 |
organic group |
167766 |
 |
organic divalent group |
166601 |
 |
organodiyl group |
166601 |
 |
carbonyl group |
166291 |
 |
carbonyl compound |
166291 |
 |
carboxylic acid |
121484 |
 |
monocarboxylic acid |
70508 |
 |
pyridinemonocarboxylic acid |
481 |
 |
nicotinic acid |
391 |
 |
| 1,4,5,6-tetrahydro-6-oxonicotinic acid |
0 |
 |
| 2,6-dihydroxynicotinic acid |
0 |
 |
| 2-aminonicotinic acid |
0 |
 |
| 4-aminonicotinic acid |
0 |
 |
| 4-methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid |
0 |
 |
| 5-aminonicotinic acid |
0 |
 |
| 5-hydroxy-6-methylpyridine-3-carboxylic acid |
0 |
 |
| 5-pyridoxic acid + |
0 |
 |
| 6-aminonicotinic acid |
0 |
 |
| 6-hydroxynicotinic acid |
0 |
 |
| D-ribosylnicotinic acid |
0 |
 |
| Euphorbia diterpenoid 2 |
0 |
 |
| N-methylnicotinic acid |
0 |
 |
| cyclitol nicotinate + |
0 |
 |
| inositol hexanicotinate + |
0 |
 |
| myo-inositol hexanicotinate |
0 |
 |
| nicotinamide + |
135 |
 |
| |
|